Skip to content

Clinical trials

Rectal Neoplasms trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rectal Neoplasms Country / region: Hong Kong Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20092
20102
20131
20172
20191
20211
20221
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status5
Active, not recruiting4
Completed3
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese University of Hong Kong3
Novartis Pharmaceuticals2
Amgen1
CCTU1
European Organisation for Research and Treatment of Cancer - EORTC1
Karen Kar Loen CHAN1
Kwong Wah Hospital1
Merck Sharp & Dohme LLC1
Mirati Therapeutics Inc.1
NantCell, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rectal Neoplasms14
Colonic Neoplasms7
Colorectal Neoplasms6
Neoplasm Metastasis3
Adenocarcinoma2
Adenocarcinoma, Clear Cell1
Anus Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Ovarian Epithelial1
Carcinoma, Renal Cell1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.